Trump and Biden Clash Over Credit for Insulin Price Cap
Former President Trump claims responsibility for reduced insulin costs, while President Biden's campaign highlights the Inflation Reduction Act's impact.
- Rep. James Clyburn criticized Trump's claims as false, pointing to Biden's legislative efforts.
- The Inflation Reduction Act, signed by Biden, capped insulin prices at $35 for Medicare recipients.
- Trump's executive action on insulin pricing was voluntary and affected fewer people.
- Biden's campaign uses the insulin price cap to contrast his achievements with Trump's tenure.
- Polls show Biden leading Trump on healthcare issues, including access to affordable insulin.